The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
Children's Hospital Los Angeles · NCT06218381
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–50 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 90
- US sites recruiting
- 1
- Study start
- March 22, 2024
- Record last updated
- July 29, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to develop a new behavioral treatment for U.S. combat veterans with post-traumatic stress disorder (PTSD), very brief exposure to combat-related stimuli. The main questions it aims to answer are:
- How does Very Brief Exposure (combat images and control everyday images) and Visible Exposure to combat stimuli affect brain activity and subjective fear ratings?
- To what extent are participants aware of the stimuli presented and tolerating the exposures?
All participants will view both very brief exposure and visible exposure to combat stimuli in the functional magnetic brain imaging (fMRI) scan. They will provide ratings of fear, awareness, and tolerability. Researchers will compare U.S. combat veterans with PTSD and healthy controls to confirm differences in brain region activation and ratings.
Being studied: Very Brief Exposure to Combat Images
Conditions: Post Traumatic Stress Disorder
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Patient Population
- Males and females ages 18-50
- Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) diagnosis of PTSD
- Traumatic event is a combat-based experience (e.g., being injured, watching a buddy be killed)
- Minimum score of 18 on the Combat Experience Scale (CES)
- Minimum score of 3 or more on Primary Care (PC)-PTSD-5
- Participants with other cooccurring psychiatric disorders (e.g., anxiety, ADHD) will be included to ensure a representative sample.
Healthy Population
- Males and Females, ages 18-50
Exclusion Criteria
Patient Population
- Treatment for PTSD, substance abuse, or mental health concerns in the past 6 months
- 10 or more years since the combat trauma
- Acute intoxication
- Severe level of Substance Dependence (6 or more DSM-V symptoms)
- Prior diagnosis of Autistic Spectrum Disorders
- Current or past psychotic disorders or active psychotic symptoms
- Current Bipolar I Disorder
- Dementia
- Neurological or serious medical conditions (e.g., stroke, epilepsy/ seizure disorder, cancer, Lupus, HIV+);
- Traumatic brain injury
Healthy Population
- Ferromagnetic implants (e.g., pacemaker), metal braces, retainers, tattoos or permanent make up w/ metallic content, transdermal medicinal patches that cannot be removed
- Neurological or serious medical conditions (e.g., stroke, epilepsy/ seizure disorder, cancer, Lupus, HIV+);
- Lifetime Diagnosis of PTSD, Tourette's Syndrome, Bipolar Disorder, Substance Dependence, Eating Disorder, Autism Spectrum Disorder, a psychotic disorder, Acute Stress Disorder
- Lifetime history of traumatic event defined as a life-threatening event involving physical attack, guns, fire or explosion (i.e the kinds of traumatic events combat veterans are likely to experience)
- Traumatic Brain Injury
- Birth at less than 37 weeks gestational age
- Claustrophobia
- Anxiety Disorder, Mood Disorder, Substance Abuse Disorder, Adjustment Disorder in past 2 years
- Treatment for mental health concern in past 2 years
- Pregnant Females
Recruiting US locations
Brain Imaging Lab
Los Angeles, CA 90027
Site contact: Courtney Marcelino · 323-361-6456 · cmarcelino@chla.usc.edu
Study contacts (from the official record)
- Courtney Marcelino · 323-361-6456 · cmarcelino@chla.usc.edu
- Bradley S Peterson, MD · 323-361-3654 · bpeterson@chla.usc.edu
Similar studies in California
All mental health studies in California →- RecruitingHealthy volunteersEarly Phase 1
Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia
Neurosterix
- Location
- Los Alamitos, CA
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Leal Therapeutics, Inc
- Location
- Los Alamitos, CA + 9 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
BioXcel Therapeutics Inc
- Location
- Anaheim, CA + 3 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingHealthy volunteersPhase 1
Inflammatory Challenge and Fear
University of California, San Francisco
- Location
- San Francisco, CA
- Eligibility basics
- Ages 18–65